Quadrature Capital »

Heron Therapeutics shares owned by Quadrature Capital

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Quadrature Capital from 13F filings

Historical chart of Quadrature Capital investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Quadrature Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Quadrature Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $296k 228k 1.30

More positions owned by Quadrature Capital

Advanced Micro Devices (AMD)
UnitedHealth (UNH)
Micron Technology (MU)
Eli Lilly & Co. (LLY)
Canadian Natl Ry (CNI)
Sandisk Corp (SNDK)
Asml Holding N V N Y Registry Shs (ASML)
Ge Vernova (GEV)
Tesla Motors (TSLA)
Stellantis SHS (STLA)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Booking Holdings (BKNG)
Agnico (AEM)
Lockheed Martin Corporation (LMT)

View all positions for Quadrature Capital

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics